相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。miR-222-5p promotes dysfunction of human vascular smooth muscle cells by targeting RB1
Yihang Liu et al.
ENVIRONMENTAL TOXICOLOGY (2022)
CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway
Yan-Ming Liu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
Human hepatocyte-enriched miRNA-192-3p promotes HBV replication through inhibiting Akt/mTOR signalling by targeting ZNF143 in hepatic cell lines
Fahong Li et al.
EMERGING MICROBES & INFECTIONS (2022)
MicroRNA-200c Attenuates the Tumor-Infiltrating Capacity of Macrophages
Rebecca Raue et al.
BIOLOGY-BASEL (2022)
Yap-Sox9 signaling determines hepatocyte plasticity and lineage-specific hepatocarcinogenesis
Yuchen Liu et al.
JOURNAL OF HEPATOLOGY (2022)
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2022)
Comprehensive analysis of GSEC/miR-101-3p/SNX16/PAPOLG axis in hepatocellular carcinoma
Shangshang Hu et al.
PLOS ONE (2022)
High Expression of EZH2 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma
Zhitao Chen et al.
GENES (2022)
Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma
Tongyu Meng et al.
FRONTIERS IN GENETICS (2022)
The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2021)
Systemic treatment of hepatocellular carcinoma: An EASL position paper
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2021)
MRPS31 loss is a key driver of mitochondrial deregulation and hepatocellular carcinoma aggressiveness
Seongki Min et al.
CELL DEATH & DISEASE (2021)
Exosomal miR-512-3p derived from mesenchymal stem cells inhibits oxidized low-density lipoprotein-induced vascular endothelial cells dysfunction via regulating Keap1
Sisi Chen et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2021)
ENO3 Inhibits Growth and Metastasis of Hepatocellular Carcinoma via Wnt/β-Catenin Signaling Pathway
Honglei Cui et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
LncRNA LINC00667 aggravates the progression of hepatocellular carcinoma by regulating androgen receptor expression as a miRNA-130a-3p sponge
Zhixiang Qin et al.
CELL DEATH DISCOVERY (2021)
Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC
Zuxiong Tang et al.
PEERJ (2021)
Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity
Pablo Fernandez-Tussy et al.
CELL DEATH & DISEASE (2021)
Mitochondrial Metabolic Signatures in Hepatocellular Carcinoma
Ho-Yeop Lee et al.
CELLS (2021)
Longitudinal Circulating Levels of miR-23b-3p, miR-126-3p and lncRNA GAS5 in HCC Patients Treated with Sorafenib
Michele Manganelli et al.
BIOMEDICINES (2021)
Extracellular vesicles transmitted miR-31-5p promotes sorafenib resistance by targeting MLH1 in renal cell carcinoma
Jinlan He et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Epidemiology and surveillance for hepatocellular carcinoma: New trends
Amit G. Singal et al.
JOURNAL OF HEPATOLOGY (2020)
Proto-Oncogene Serine/Threonine Kinase PIM3 Promotes Cell Migration via Modulating Rho GTPase Signaling
Yamei Dang et al.
JOURNAL OF PROTEOME RESEARCH (2020)
Exosomal MicroRNAs as Liquid Biopsy Biomarkers in Hepatocellular Carcinoma
Shuo Wang et al.
ONCOTARGETS AND THERAPY (2020)
Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
Federico Pinero et al.
CELLS (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma
Qiuyue Hu et al.
DISEASE MARKERS (2020)
Downregulation of thioredoxin-1-dependent CD95 S-nitrosation by Sorafenib reduces liver cancer
Raul Gonzalez et al.
REDOX BIOLOGY (2020)
Exosomal miR-200c-3p negatively regulates the migraion and invasion of lipopolysaccharide (LPS)-stimulated colorectal cancer (CRC)
Yimei Jiang et al.
BMC MOLECULAR AND CELL BIOLOGY (2020)
Liquid biopsy in the clinical management of hepatocellular carcinoma
Johann von Felden et al.
GUT (2020)
Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma
Tomoki Kohno et al.
ONCOLOGY LETTERS (2020)
Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells
Maria A. Rodriguez-Hernandez et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
Michael Teufel et al.
GASTROENTEROLOGY (2019)
Dedifferentiation of Primary Hepatocytes is Accompanied with Reorganization of Lipid Metabolism Indicated by Altered Molecular Lipid and miRNA Profiles
Mostafa Kiamehr et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Biology and significance of alpha-fetoprotein in hepatocellular carcinoma
Peter R. Galle et al.
LIVER INTERNATIONAL (2019)
A Large Set of miRNAs Is Dysregulated from the Earliest Steps of Human Hepatocellular Carcinoma Development
Pia Sulas et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
MicroRNA 200c-3p regulates autophagy via upregulation of endoplasmic reticulum stress in PC-3 cells
Eun Jung Sohn
CANCER CELL INTERNATIONAL (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy
M. Gugnoni et al.
ONCOGENE (2017)
Ubenimex suppresses Pim-3 kinase expression by targeting CD13 to reverse MDR in HCC cells
Qie Guo et al.
ONCOTARGET (2017)
The role of autophagy in hepatocellular carcinoma: friend or foe
Lian Liu et al.
ONCOTARGET (2017)
In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3-Mediated Apoptosis
Francesca Fornari et al.
CLINICAL CANCER RESEARCH (2017)
Metallothionein-1G Facilitates Sorafenib Resistance Through Inhibition of Ferroptosis
Xiaofang Sun et al.
HEPATOLOGY (2016)
Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro
Zhen Qu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Chenodeoxycholic acid significantly impacts the expression of miRNAs and genes involved in lipid, bile acid and drug metabolism in human hepatocytes
Regina Krattinger et al.
LIFE SCIENCES (2016)
SNAI1 promotes the development of HCC through the enhancement of proliferation and inhibition of apoptosis
Jianni Qi et al.
FEBS OPEN BIO (2016)
被撤回的出版物: miR-222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma (Retracted article. See vol. 59, 2021)
Kai Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Clinical significance and therapeutic value of glutathione peroxidase 3 (GPx3) in hepatocellular carcinoma
Xiang Qi et al.
ONCOTARGET (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma
Wen Wang et al.
CARCINOGENESIS (2012)
Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
Josep M. Llovet et al.
CLINICAL CANCER RESEARCH (2012)
MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo
X-X He et al.
ONCOGENE (2012)
Micro-RNA expression in cisplatin resistant germ cell tumor cell lines
Matthias Port et al.
MOLECULAR CANCER (2011)
MiR-222 Overexpression Confers Cell Migratory Advantages in Hepatocellular Carcinoma through Enhancing AKT Signaling
Queenie W-L. Wong et al.
CLINICAL CANCER RESEARCH (2010)
Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver
Y. Wu et al.
ONCOGENE (2010)
Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study
Zhe Zhang et al.
BMC MEDICINE (2009)
α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
Jorge A. Marrero et al.
GASTROENTEROLOGY (2009)
Hep G2 is a hepatoblastoma-derived cell line
Dolores Lopez-Terrada et al.
HUMAN PATHOLOGY (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties
C. Coulouarn et al.
ONCOGENE (2009)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma
PH Yin et al.
BRITISH JOURNAL OF CANCER (2004)
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
VK Mootha et al.
NATURE GENETICS (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)